Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The molecular and stromal landscape of salivary duct carcinoma reveals new therapeutic opportunities

ABSTRACT: Purpose: RNA-sequencing data was used to determine the main molecular pathways invovled in SDC and describe the tumoral microenvironment composition with key cellular networks within the latter.

ORGANISM(S): Homo sapiens

PROVIDER: GSE138581 | GEO | 2020/02/12

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities.

Project description: Not available

| S-EPMC7150470 | biostudies-literature

The molecular and stromal landscape of salivary duct carcinoma reveals new therapeutic opportunities

Project description:The molecular and stromal landscape of salivary duct carcinoma reveals new therapeutic opportunities

| PRJNA576455 | ENA

salivary duct carcinoma genomics

Project description:Salivary duct carcinoma is a rare and aggressive salivary gland cancer subtype with poor prognosis. Its mutational landscape has been described rather exhaustively but little is known regarding its functional genomics and tumor microenvironment. In this study, we combined transcriptomics and proteomics to obtain a first characterization of deregulated pathways, which revealed the importance of Notch, TGB-β, and interferon-γ signaling. We then associated computational biology, immunohistochemistry, multiplexed immunofluorescence, and digital imaging to start charting the cellular network within the microenvironment, identify two well-defined groups of tumors according to their immune infiltrate, find novel SDC immune checkpoints, and show the role macrophages and NK cells in immunosuppression. Furthermore, we showed a clear trend between recurrence free survival and M2 macrophage abundance, and, independently, α-SMA abundance – a measure of desmoplastic stromal reaction. Altogether, these many findings open new perspectives for SDC. Classical patient stratification according to the immune infiltrate should be applied before choosing an immunotherapy. The microenvironment offers new actionable targets such as macrophages or NK cells, or even fibroblasts or hyaluronic acid in the absence of immune infiltrate. Related therapies are developed e.g. against pancreatic tumors that could inspire equivalents for SDC. Combinations with drugs targeting SDC mutated genes might also contribute to patient-specific regimens.

2020-05-26 | PXD015885 | Pride

Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy.

Project description: Not available

| S-EPMC5685667 | biostudies-literature

Somatic mutations in salivary duct carcinoma and potential therapeutic targets.

Project description: Not available

| S-EPMC5652672 | biostudies-literature

Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities.

Project description: Not available

| S-EPMC6434696 | biostudies-literature

Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling.

Project description: Not available

| S-EPMC6885888 | biostudies-literature

Glycolytic shift during West Nile virus infection provides new therapeutic opportunities

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-09-27 | GSE233218 | GEO

Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.

Project description: Not available

| S-EPMC3929114 | biostudies-literature

Glycolytic shift during West Nile virus infection provides new therapeutic opportunities [Brain]

Project description:To investigate the in vivo metabolic changes during WNV infection in a mouse model, we infected mice with WNV NY99 to compare to uninfected (mock) mice. We also use two compounds targeting energetic metabolism to analysed their effects on WNV infection We then performed gene expression profiling analysis using data obtained from RNA-seq from infected vs uninfected mice and treated mice.

2023-09-27 | GSE233216 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data